News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Rubrik's ARR is growing about 33% year-over-year to roughly $1.66 billion.
  • The company reports high gross margins.
  • Free cash flow is positive and accelerating.
  • Shares trade at an elevated price-to-sales of about 13.5.
  • Analyst recommends a tactical long with specified entry, stop and target over a 180-trading-day horizon.
  • Thesis highlights improving unit economics as the primary catalyst for upside.
  • Trade plan explicitly lists catalysts and includes stop-loss risk controls.

Latest Articles

Mattel: Deep Value Play with Clear Catalysts and a Path to $20

Mattel: Deep Value Play with Clear Catalysts and a Path to $20

Mattel is trading at a single-digit earnings multiple, generating positive free cash flow, and sitting on strong global franchises. Near-term noise on margins and FX has driven the stock lower; we see a disciplined long trade with defined risk and 40-80% upside if catalysts play out over the next 3-6 months.

Macy's: Turnaround Momentum, Cheap Valuation and a Clear Risk/Reward

Macy's: Turnaround Momentum, Cheap Valuation and a Clear Risk/Reward

Macy's has delivered its strongest quarter in years, raised guidance, and attracted a material stake from Berkshire Hathaway. At roughly $23.70 and trading below a single-digit P/E on some metrics, the stock offers a favorable risk/reward for a long trade. This idea lays out an entry at $24.00, a $30.00 target and a $20.50 stop, with a 180-trading-…

Teradyne 2027 Play: Buy the 2026 Dip With 2027 in Mind

Teradyne 2027 Play: Buy the 2026 Dip With 2027 in Mind

Teradyne has re-rated on AI-driven semiconductor test demand and robotics growth. Near-term lumpiness and margin noise will keep the stock volatile, but the company's scale in semicon test, improving cash generation, and index inclusion create a path to meaningful upside by 2027. This trade targets a recovery toward prior highs with a clear stop to…

Quanta Services: Buy the Grid Play Powering the AI Buildout

Quanta Services: Buy the Grid Play Powering the AI Buildout

Quanta Services sits at the physical intersection of AI demand and electric infrastructure. Backlog, free cash flow and a new buyback create a constructive setup despite a premium multiple. This is a swing trade: buy the pullback around current levels with a mid-term horizon while watching execution and margin trends closely.

4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population

4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population

4D Molecular Therapeutics revealed positive two-year results from its PRISM Phase 2b clinical trial for 4D-150, an intravitreal gene therapy targeting wet age-related macular degeneration (AMD). The therapy demonstrated sustained visual acuity, anatomical control, and a significant reduction in treatment burden with a favorable safety profile. Thes…

Autodesk Is an AI-Era Value Play — Buy the Dip, Back the Execution

Autodesk Is an AI-Era Value Play — Buy the Dip, Back the Execution

Autodesk shares trade well below last year's highs despite strong cash generation, a recent strategic M&A bolt-on and early signs management is leaning into AI. With market cap ~ $46.1B, free cash flow of $2.73B and an EV/EBITDA of ~17.2, the risk/reward favors a long entry now for traders who want to back a recovery and AI re-rating over the next …

AMD Into Earnings: A Measured Long on a Pullback Before 8/04 Print

AMD Into Earnings: A Measured Long on a Pullback Before 8/04 Print

Advanced Micro Devices (AMD) faces a binary August 4 earnings print. The stock is trading well below its June highs after a semiconductor sector pullback. With a market cap near $808B, chunky free cash flow and aggressive revenue growth targets priced into the shares, this trade favors disciplined, size-managed long exposure on a pullback to suppor…

Buy the Dip: Waste Management Looks Worth Owning After Pullback

Buy the Dip: Waste Management Looks Worth Owning After Pullback

Waste Management (WM) recently underperformed but still trades inside a constructive range with solid fundamentals: ~$96B market cap, $3.29B in free cash flow, and a 23-year dividend growth streak. Pair those fundamentals with a fresh $3B buyback, AI-driven efficiency gains, and a resilient end-market and you have an asymmetric trade. I recommend a…

UFC Names Meridian Holdings Official Sponsor of Fight Night Belgrade

UFC Names Meridian Holdings Official Sponsor of Fight Night Belgrade

Meridian Holdings Inc., through its subsidiary Meridianbet, has been named the official sponsor of UFC Fight Night Serbia, scheduled for August 1, 2026. This marks the first UFC event in Serbia and highlights Meridianbet's significant brand presence in combat sports and international markets. The partnership will feature extensive branding and medi…

Buy the Next-Gen AI Dip: Nvidia’s Stack Is Poised for a Re-Rate

Buy the Next-Gen AI Dip: Nvidia’s Stack Is Poised for a Re-Rate

Nvidia is trading below recent highs after a sector-wide pullback. Fundamentals remain strong: a $4.985T market cap, 81.7% ROE, $119B free cash flow and an EPS of $6.59. We lay out a mid-term long trade (45 trading days) with an entry at $200.00, stop at $188.00 and a target at $260.00, backed by product catalysts around HBM4 and next-generation ar…

Yext: Scout-Led Re-Acceleration Could Make $YEXT a Tactical Long

Yext: Scout-Led Re-Acceleration Could Make $YEXT a Tactical Long

Yext is a sub-$1B market-cap SaaS name where product evolution around a 'Scout' intelligent search layer could re-risk growth while valuation already discounts a muted outcome. The company generates positive free cash flow ($53M last reported), carries an enterprise value of roughly $591M and trades around $5.35. This trade targets a mid-term rebou…

What Every XFLT Shareholder Needs to Know for XFLT's Proxy Contest

What Every XFLT Shareholder Needs to Know for XFLT's Proxy Contest

XAI Investments LLC, manager of XAI Floating Rate & Alternative Income Trust (XFLT), addresses shareholder concerns amidst a proxy contest regarding the approval of a new sub-advisory agreement with King Street Capital Management. The firm refutes claims from the terminated sub-adviser Octagon about fee increases and highlights Octagon's poor perfo…

Buy STIM on Growth and Cheap P/S; Watch Margins and Cash Flow

Buy STIM on Growth and Cheap P/S; Watch Margins and Cash Flow

Neuronetics (STIM) is a small-cap medical technology name with accelerating revenue drivers in transcranial magnetic stimulation (TMS) and an attractive price-to-sales of 0.74. The stock trades near $1.62 with an enterprise value of roughly $160.8M, leaving room for a re-rate if adoption and reimbursement continue to improve. However, negative marg…